Protein Engineering Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 to 4 weeks by ordering today
The future of the protein engineering market looks promising with opportunities in biopharmaceutical companies, contract research organizations, and academic research institutes. The global protein engineering market is expected to grow with a CAGR of 14%-18% from 2020 to 2025. The major drivers for this market are rise in investment in synthetic biology and increasing protein-based drug development by pharmaceutical & biotechnology companies.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global protein engineering market report, please download the report brochure.
In this market, instruments is the largest product & service segment of protein engineering, whereas biopharmaceutical companies is the largest end user. Growth in various segments of the protein engineering market are given below:
The study includes trends and forecast for the global protein engineering market by product & service, protein type, technology, end user, and region as follows:
By Product & Service [Value ($ Million) shipment analysis for 2014 – 2025]:
Lucintel forecasts that instruments will remain the largest product & service segment over the forecast period due to the extensive usage of new technologies and process advancements in proteomic research and high preference for automated technology by researchers in order to facilitate a faster molecule development process.
Within this market, biopharmaceutical companies will remain the largest end user segment over the forecast period due to the wide use of protein engineering in drug discovery and development of models to develop a broad range of protein-based drugs.
North America will remain the largest region over the forecast period due to the presence of a large number of pharmaceutical and biotechnology companies & a well-established healthcare market, rising R&D expenditure, and the availability of the latest techniques & instruments for drug discovery research in the region.
Features of the Global Protein Engineering Market
Q.1 What are some of the most promising potential, high-growth opportunities for the global protein engineering market by product & service (instruments, consumables, and software & services), protein type (monoclonal antibodies, erythropoietin, interferons, vaccines, colony-stimulating factors, growth hormones, coagulation factors, and other proteins), technology (rational protein design and irrational protein design), end user (biopharmaceutical companies, contract research organizations, and academic research institutes), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global protein engineering market?
Q.5 What are the business risks and threats to the global protein engineering market?
Q.6 What are the emerging trends in this protein engineering market and the reasons behind them?
Q.7 What are some changing demands of customers in this protein engineering market?
Q.8 What are the new developments in this protein engineering market? Which companies are leading these developments?
Q.9 Who are the major players in this protein engineering market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive product and processes in this protein engineering market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global protein engineering market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product & Service & Service (Instruments, Consumables, and Software & Services), Protein Type (Monoclonal Antibodies, Erythropoietin, Interferons, Vaccines, Colony-Stimulating Factors, Growth Hormones, Coagulation Factors, and Other Proteins), Technology (Rational Protein Design and Irrational Protein Design), and End User (Biopharmaceutical Companies, Contract Research Organizations, and Academic Research Institutes)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
The future of the protein engineering market looks promising with opportunities in biopharmaceutical companies, contract research organizations, and academic research institutes. The global protein engineering market is expected to grow with a CAGR of 14%-18% from 2020 to 2025. The major drivers for this market are rise in investment in synthetic biology and increasing protein-based drug development by pharmaceutical & biotechnology companies.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global protein engineering market report, please download the report brochure.
In this market, instruments is the largest product & service segment of protein engineering, whereas biopharmaceutical companies is the largest end user. Growth in various segments of the protein engineering market are given below:
The study includes trends and forecast for the global protein engineering market by product & service, protein type, technology, end user, and region as follows:
By Product & Service [Value ($ Million) shipment analysis for 2014 – 2025]:
- Instruments
- Consumables
- Software & Services
- Monoclonal Antibodies
- Erythropoietin
- Interferons
- Vaccines
- Colony-Stimulating Factors
- Growth Hormones
- Coagulation Factors
- Other Proteins
- Rational Protein Design
- Irrational Protein Design
- Biopharmaceutical Companies
- Contract Research Organizations
- Academic Research Institutes
- North America
- United States
- Canada
- Mexico
- Europe
- United Kingdom
- Spain
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- The Rest of the World
- Brazil
Lucintel forecasts that instruments will remain the largest product & service segment over the forecast period due to the extensive usage of new technologies and process advancements in proteomic research and high preference for automated technology by researchers in order to facilitate a faster molecule development process.
Within this market, biopharmaceutical companies will remain the largest end user segment over the forecast period due to the wide use of protein engineering in drug discovery and development of models to develop a broad range of protein-based drugs.
North America will remain the largest region over the forecast period due to the presence of a large number of pharmaceutical and biotechnology companies & a well-established healthcare market, rising R&D expenditure, and the availability of the latest techniques & instruments for drug discovery research in the region.
Features of the Global Protein Engineering Market
- Market Size Estimates: Global protein engineering market size estimation in terms of value ($M) shipment.
- Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.
- Segmentation Analysis: Global protein engineering market size by various segments, such as product & service, protein type, technology, and end user in terms of value.
- Regional Analysis: Global protein engineering market breakdown by the North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different product & service, protein type, technology, end user, and region for the global protein engineering market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global protein engineering market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
Q.1 What are some of the most promising potential, high-growth opportunities for the global protein engineering market by product & service (instruments, consumables, and software & services), protein type (monoclonal antibodies, erythropoietin, interferons, vaccines, colony-stimulating factors, growth hormones, coagulation factors, and other proteins), technology (rational protein design and irrational protein design), end user (biopharmaceutical companies, contract research organizations, and academic research institutes), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global protein engineering market?
Q.5 What are the business risks and threats to the global protein engineering market?
Q.6 What are the emerging trends in this protein engineering market and the reasons behind them?
Q.7 What are some changing demands of customers in this protein engineering market?
Q.8 What are the new developments in this protein engineering market? Which companies are leading these developments?
Q.9 Who are the major players in this protein engineering market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive product and processes in this protein engineering market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global protein engineering market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product & Service & Service (Instruments, Consumables, and Software & Services), Protein Type (Monoclonal Antibodies, Erythropoietin, Interferons, Vaccines, Colony-Stimulating Factors, Growth Hormones, Coagulation Factors, and Other Proteins), Technology (Rational Protein Design and Irrational Protein Design), and End User (Biopharmaceutical Companies, Contract Research Organizations, and Academic Research Institutes)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Protein Engineering Market Trends and Forecast
3.3: Global Protein Engineering Market by Product & Service
3.3.1: Instruments
3.3.2: Consumables
3.3.3: Software & Services
3.4: Global Protein Engineering Market by Protein Type
3.4.1: Monoclonal Antibodies
3.4.2: Erythropoietin
3.4.3: Interferons
3.4.4: Vaccines
3.4.5: Colony-Stimulating Factors
3.4.6: Growth Hormones
3.4.7: Coagulation Factors
3.4.8: Other Proteins
3.5: Global Protein Engineering Market by Technology
3.5.1: Rational Protein Design
3.5.2: Irrational Protein Design
3.6: Global Protein Engineering Market by End User
3.6.1: Biopharmaceutical Companies
3.6.2: Contract Research Organizations
3.6.3: Academic Research Institutes
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Protein Engineering Market by Region
4.2: North American Protein Engineering Market
4.2.1: Market by Product & Service: Instruments, Consumables, and Software & Services
4.2.2: Market by Protein Type: Monoclonal Antibodies, Erythropoietin, Interferons, Vaccines, Colony-Stimulating Factors, Growth Hormones, Coagulation Factors, and Other Proteins
4.2.3: Market by Technology: Rational Protein Design and Irrational Protein Design
4.2.4: Market by End User: Biopharmaceutical Companies, Contract Research Organizations, and Academic Research Institutes
4.2.5: The United States Protein Engineering Market
4.2.6: The Canadian Protein Engineering Market
4.2.7: The Mexican Protein Engineering Market
4.3: European Protein Engineering Market
4.3.1: Market by Product & Service: Instruments, Consumables, and Software & Services
4.3.2: Market by Protein Type: Monoclonal Antibodies, Erythropoietin, Interferons, Vaccines, Colony-Stimulating Factors, Growth Hormones, Coagulation Factors, and Other Proteins
4.3.3: Market by Technology: Rational Protein Design and Irrational Protein Design
4.3.4: Market by End User: Biopharmaceutical Companies, Contract Research Organizations, and Academic Research Institutes
4.3.5: The United Kingdom Protein Engineering Market
4.3.6: The Spanish Protein Engineering Market
4.3.7: The German Protein Engineering Market
4.3.8: The French Protein Engineering Market
4.4: APAC Protein Engineering Market
4.4.1: Market by Product & Service: Instruments, Consumables, and Software & Services
4.4.2: Market by Protein Type: Monoclonal Antibodies, Erythropoietin, Interferons, Vaccines, Colony-Stimulating Factors, Growth Hormones, Coagulation Factors, and Other Proteins
4.4.3: Market by Technology: Rational Protein Design and Irrational Protein Design
4.4.4: Market by End User: Biopharmaceutical Companies, Contract Research Organizations, and Academic Research Institutes
4.4.5: The Chinese Protein Engineering Market
4.4.6: The Indian Protein Engineering Market
4.4.7: The Japanese Protein Engineering Market
4.5: ROW Protein Engineering Market
4.5.1: Market by Product & Service: Instruments, Consumables, and Software & Services
4.5.2: Market by Protein Type: Monoclonal Antibodies, Erythropoietin, Interferons, Vaccines, Colony-Stimulating Factors, Growth Hormones, Coagulation Factors, and Other Proteins
4.5.3: Market by Technology: Rational Protein Design and Irrational Protein Design
4.5.4: Market by End User: Biopharmaceutical Companies, Contract Research Organizations, and Academic Research Institutes
4.5.5: Brazilian Protein Engineering Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Protein Engineering Market by Product & Service
7.1.2: Growth Opportunities for the Global Protein Engineering Market by Protein Type
7.1.3: Growth Opportunities for the Global Protein Engineering Market by Technology
7.1.4: Growth Opportunities for the Global Protein Engineering Market by End User
7.1.5: Growth Opportunities for the Global Protein Engineering Market by Region
7.2: Emerging Trends in the Global Protein Engineering Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Protein Engineering Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Protein Engineering Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Merck KGaA
8.2: Bio-Rad Laboratories
8.3: Danaher
8.4: Therm Fisher Scientific
8.5: GE Healthcare
8.6: Company
8.7: Company
8.8: Company
8.9: Company
8.10: Company
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Protein Engineering Market Trends and Forecast
3.3: Global Protein Engineering Market by Product & Service
3.3.1: Instruments
3.3.2: Consumables
3.3.3: Software & Services
3.4: Global Protein Engineering Market by Protein Type
3.4.1: Monoclonal Antibodies
3.4.2: Erythropoietin
3.4.3: Interferons
3.4.4: Vaccines
3.4.5: Colony-Stimulating Factors
3.4.6: Growth Hormones
3.4.7: Coagulation Factors
3.4.8: Other Proteins
3.5: Global Protein Engineering Market by Technology
3.5.1: Rational Protein Design
3.5.2: Irrational Protein Design
3.6: Global Protein Engineering Market by End User
3.6.1: Biopharmaceutical Companies
3.6.2: Contract Research Organizations
3.6.3: Academic Research Institutes
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Protein Engineering Market by Region
4.2: North American Protein Engineering Market
4.2.1: Market by Product & Service: Instruments, Consumables, and Software & Services
4.2.2: Market by Protein Type: Monoclonal Antibodies, Erythropoietin, Interferons, Vaccines, Colony-Stimulating Factors, Growth Hormones, Coagulation Factors, and Other Proteins
4.2.3: Market by Technology: Rational Protein Design and Irrational Protein Design
4.2.4: Market by End User: Biopharmaceutical Companies, Contract Research Organizations, and Academic Research Institutes
4.2.5: The United States Protein Engineering Market
4.2.6: The Canadian Protein Engineering Market
4.2.7: The Mexican Protein Engineering Market
4.3: European Protein Engineering Market
4.3.1: Market by Product & Service: Instruments, Consumables, and Software & Services
4.3.2: Market by Protein Type: Monoclonal Antibodies, Erythropoietin, Interferons, Vaccines, Colony-Stimulating Factors, Growth Hormones, Coagulation Factors, and Other Proteins
4.3.3: Market by Technology: Rational Protein Design and Irrational Protein Design
4.3.4: Market by End User: Biopharmaceutical Companies, Contract Research Organizations, and Academic Research Institutes
4.3.5: The United Kingdom Protein Engineering Market
4.3.6: The Spanish Protein Engineering Market
4.3.7: The German Protein Engineering Market
4.3.8: The French Protein Engineering Market
4.4: APAC Protein Engineering Market
4.4.1: Market by Product & Service: Instruments, Consumables, and Software & Services
4.4.2: Market by Protein Type: Monoclonal Antibodies, Erythropoietin, Interferons, Vaccines, Colony-Stimulating Factors, Growth Hormones, Coagulation Factors, and Other Proteins
4.4.3: Market by Technology: Rational Protein Design and Irrational Protein Design
4.4.4: Market by End User: Biopharmaceutical Companies, Contract Research Organizations, and Academic Research Institutes
4.4.5: The Chinese Protein Engineering Market
4.4.6: The Indian Protein Engineering Market
4.4.7: The Japanese Protein Engineering Market
4.5: ROW Protein Engineering Market
4.5.1: Market by Product & Service: Instruments, Consumables, and Software & Services
4.5.2: Market by Protein Type: Monoclonal Antibodies, Erythropoietin, Interferons, Vaccines, Colony-Stimulating Factors, Growth Hormones, Coagulation Factors, and Other Proteins
4.5.3: Market by Technology: Rational Protein Design and Irrational Protein Design
4.5.4: Market by End User: Biopharmaceutical Companies, Contract Research Organizations, and Academic Research Institutes
4.5.5: Brazilian Protein Engineering Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Protein Engineering Market by Product & Service
7.1.2: Growth Opportunities for the Global Protein Engineering Market by Protein Type
7.1.3: Growth Opportunities for the Global Protein Engineering Market by Technology
7.1.4: Growth Opportunities for the Global Protein Engineering Market by End User
7.1.5: Growth Opportunities for the Global Protein Engineering Market by Region
7.2: Emerging Trends in the Global Protein Engineering Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Protein Engineering Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Protein Engineering Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Merck KGaA
8.2: Bio-Rad Laboratories
8.3: Danaher
8.4: Therm Fisher Scientific
8.5: GE Healthcare
8.6: Company
8.7: Company
8.8: Company
8.9: Company
8.10: Company
